Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin M Posadas

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Nature Reviews. Urology|October 14, 2025
Therapeutic targeting of prostate-specific membrane antigen could limit its potential as benchmark imagingMelissa L Abel, Adam Sharp, Edwin M Posadas, et al.
American Journal of Clinical and Experimental Urology|April 19, 2018
Structure and function analysis in circulating tumor cells: using nanotechnology to study nuclear size in prostate cancerNu Yao, Yu-Jen Jan, Shirley Cheng, et al.
Oncotarget|November 21, 2017
Modulation of cabozantinib efficacy by the prostate tumor microenvironmentManisha Tripathi, Srinivas Nandana, Sandrine Billet, et al.
Cancer Biology & Therapy|April 26, 2007
A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinomaEdwin M Posadas, Samir Undevia, Elizabeth Manchen, et al.
Endocrine-Related Cancer|June 9, 2020
COVID-19 and androgen-targeted therapy for prostate cancer patientsNeil A Bhowmick, Jillian Oft, Tanya Dorff, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNAMichael M Murata, Fumie Igari, Ryan Urbanowicz, et al.
Nature Reviews. Urology|February 11, 2010
Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathyPeter H O'Donnell, Ana Jensen, Edwin M Posadas, et al.
American Journal of Clinical and Experimental Urology|September 20, 2021
Scaffold attachment factor B1 regulates androgen degradation pathways in prostate cancerJulie Suan-Wei Yang, Chen Qian, Sungyong You, et al.
Theranostics|July 5, 2016
Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor CellsJie-Fu Chen, Yazhen Zhu, Yi-Tsung Lu, et al.
Endocrine-Related Cancer|November 12, 2025
ONECUT2: a validated drug target and lineage plasticity driver in prostate cancer and other malignanciesMichael R Freeman, Lillian M Perez, Qian Yang, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Nature Reviews. Urology|October 14, 2025
Therapeutic targeting of prostate-specific membrane antigen could limit its potential as benchmark imagingMelissa L Abel, Adam Sharp, Edwin M Posadas, et al.
American Journal of Clinical and Experimental Urology|April 19, 2018
Structure and function analysis in circulating tumor cells: using nanotechnology to study nuclear size in prostate cancerNu Yao, Yu-Jen Jan, Shirley Cheng, et al.
Oncotarget|November 21, 2017
Modulation of cabozantinib efficacy by the prostate tumor microenvironmentManisha Tripathi, Srinivas Nandana, Sandrine Billet, et al.
Cancer Biology & Therapy|April 26, 2007
A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinomaEdwin M Posadas, Samir Undevia, Elizabeth Manchen, et al.
Endocrine-Related Cancer|June 9, 2020
COVID-19 and androgen-targeted therapy for prostate cancer patientsNeil A Bhowmick, Jillian Oft, Tanya Dorff, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNAMichael M Murata, Fumie Igari, Ryan Urbanowicz, et al.
Nature Reviews. Urology|February 11, 2010
Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathyPeter H O'Donnell, Ana Jensen, Edwin M Posadas, et al.
American Journal of Clinical and Experimental Urology|September 20, 2021
Scaffold attachment factor B1 regulates androgen degradation pathways in prostate cancerJulie Suan-Wei Yang, Chen Qian, Sungyong You, et al.
Theranostics|July 5, 2016
Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor CellsJie-Fu Chen, Yazhen Zhu, Yi-Tsung Lu, et al.
Endocrine-Related Cancer|November 12, 2025
ONECUT2: a validated drug target and lineage plasticity driver in prostate cancer and other malignanciesMichael R Freeman, Lillian M Perez, Qian Yang, et al.
Pageof 12